Skip to main content
. 2013 Mar 13;52(4):776–782. doi: 10.3109/0284186X.2013.770920

Figure 2.

Figure 2.

Normalised tumour volume growth of the human GIST AHAX xenograft in mice receiving either imatinib (100 mg/kg/day) continuously, intermittently (one week on, one week off) or placebo (water). At the end of experiment, mice with particularly large tumours were scarified, causing a dip in tumour volume growth (the light grey symbols). The data are given as means and standard errors of the means.